Physiologic and pathophysiologic roles of lipid mediators in the kidney (Q36760012)

16 August 2017

1 reference

title

Physiologic and pathophysiologic roles of lipid mediators in the kidney (English)

1 reference

16 August 2017

1 reference

Hao CM

1

1 reference

16 August 2017

Breyer MD

series ordinal

2

1 reference

16 August 2017

language of work or name

English

0 references

publication date

14 March 2007

1 reference

16 August 2017

1 reference

16 August 2017

volume

71

1 reference

16 August 2017

issue

11

1 reference

16 August 2017

page(s)

1105-1115

1 reference

Arachidonic acid as a bioactive molecule

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Prostaglandins and leukotrienes: advances in eicosanoid biology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Regulated formation of eicosanoids

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

COX in a crystal ball: current status and future promise of prostaglandin research

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Microsomal cytochrome P450 and eicosanoid metabolism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Cyclooxygenase-1 and -2 isoenzymes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Phospholipase A2 enzymes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Cytosolic phospholipase A2: biochemical properties and physiological roles

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

A novel arachidonic acid-selective cytosolic PLA2 contains a Ca(2+)-dependent translocation domain with homology to PKC and GAP

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Purification of a 110-kilodalton cytosolic phospholipase A2 from the human monocytic cell line U937.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Activation of phospholipase A2 by endothelin in cultured vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Endothelin-1 stimulates cytosolic phospholipase A2 activity and gene expression in rat glomerular mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Phospholipase A2-mediated activation of mitogen-activated protein kinase by angiotensin II

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Stimulation of arachidonic acid release by vasopressin in A7r5 vascular smooth muscle cells mediated by Ca2+-stimulated phospholipase A2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Role of reactive oxygen in phospholipase A2 activation by ischemia/reperfusion of the rat kidney

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

The actin cytoskeleton facilitates complement-mediated activation of cytosolic phospholipase A2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Hypoxia increases group IIA phospholipase A(2) expression under inflammatory conditions in rat renal mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Cyclic stretch-induced cPLA2 mediates ERK 1/2 signaling in rabbit proximal tubule cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Cytosolic phospholipase A2 (PLA2), but not secretory PLA2, potentiates hydrogen peroxide cytotoxicity in kidney epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

PLIP, a novel splice variant of Tip60, interacts with group IV cytosolic phospholipase A(2), induces apoptosis, and potentiates prostaglandin production

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Group V secretory phospholipase A2-modified low density lipoprotein promotes foam cell formation by a SR-A- and CD36-independent process that involves cellular proteoglycans.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Cooperation between secretory phospholipase A2 and TNF-receptor superfamily signaling: implications for the inflammatory response in atherogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

New phospholipase A2 isozymes with a potential role in atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Prostaglandin synthase 2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Prostaglandin receptors: their role in regulating renal function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Genetic and pharmacological analysis of prostanoid receptor function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Peroxisome proliferator-activated receptor delta activation promotes cell survival following hypertonic stress

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

PPAR delta functions as a prostacyclin receptor in blastocyst implantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Role of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) and its natural ligand 15-deoxy-Delta12, 14-prostaglandin J2 in the regulation of microglial functions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

PPAR gamma ligands, 15-deoxy-delta12,14-prostaglandin J2 and rosiglitazone regulate human cultured airway smooth muscle proliferation through different mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Identification of a phorbol ester-repressible v-src-inducible gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Human cyclooxygenase-2 cDNA

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Why there are two cyclooxygenase isozymes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Multiple female reproductive failures in cyclooxygenase 2-deficient mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Inhibition of cyclooxygenase-2 in the rat renal medulla leads to sodium-sensitive hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Adverse effects of cyclooxygenase 2 inhibitors on renal and arrhythmia events: meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

COX-2 and beyond: Approaches to prostaglandin inhibition in human disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Identification and characterization of a novel type of membrane-associated prostaglandin E synthase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Biochemical characterization of mouse microsomal prostaglandin E synthase-1 and its colocalization with cyclooxygenase-2 in peritoneal macrophages

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Prostaglandin E synthase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Lipocalin-type and hematopoietic prostaglandin D synthases as a novel example of functional convergence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Biochemical, structural, genetic, physiological, and pathophysiological features of lipocalin-type prostaglandin D synthase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Prostaglandin F synthase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Purification and partial characterization of an NADH-linked Δ13-15-ketoprostaglandin reductase from human placenta

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Membrane-associated PGE synthase-1 (mPGES-1) is coexpressed with both COX-1 and COX-2 in the kidney

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Gene expression of prostanoid forming enzymes along the rat nephron

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Expression of mouse membrane-associated prostaglandin E2 synthase-2 (mPGES-2) along the urogenital tract.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Genomic structure and genitourinary expression of mouse cytosolic prostaglandin E2 synthase gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Differentiation of cyclooxygenase 1- and 2-derived prostanoids in mouse kidney and aorta

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

G protein-coupled prostanoid receptors and the kidney

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Expression of the prostaglandin F receptor (FP) gene along the mouse genitourinary tract

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Fetal immunization of baboons induces a fetal-specific antibody response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Reproductive failure and reduced blood pressure in mice lacking the EP2 prostaglandin E2 receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Prostaglandins and nonsteroidal anti-inflammatory drugs. Effects on renal hemodynamics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

The Effect of Indomethacin on Proteinuria and Kidney Function in the Nephrotic Syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Abdominal pain associated with IgA nephropathy. Possible mechanism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Incidence of ocular melanoma in the general population and in glaucoma patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet. A randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Renal changes induced by a cyclooxygenase-2 inhibitor during normal and low sodium intake

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Cyclooxygenase-2 selective inhibitors and the kidney

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Effect of prostanoids on renin release from rabbit afferent arterioles with and without macula densa

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Haemorrhage-induced secretion of active and inactive renin in conscious and pentobarbitone-anaesthetized sheep.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Mechanism of preservation of glomerular perfusion and filtration during acute extracellular fluid volume depletion. Importance of intrarenal vasopressin-prostaglandin interaction for protecting kidneys from constrictor action of vasopressin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Eicosanoids and renal vascular function in diseases.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Role of EP2 and EP4 receptor-selective agonists of prostaglandin E(2) in acute and chronic kidney failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Prostaglandins: effects on blood pressure, renal blood flow, sodium and water excretion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Identification of prostaglandin E2 as the principal vasodepressor lipid of rabbit renal medulla.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Nonsteroidal anti-inflammatory drugs (NSAIDs) and blood pressure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Relation between renin release and blood pressure response to nonsteroidal anti-inflammatory drugs in hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Expression and function of COX isoforms in renal medulla: evidence for regulation of salt sensitivity and blood pressure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Mechanisms underlying the antihypertensive functions of the renal medulla

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Prostacyclin protects against elevated blood pressure and cardiac fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Prostaglandin E2 inhibits renal collecting duct Na+ absorption by activating the EP1 receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Genetic deletion of COX-2 prevents increased renin expression in response to ACE inhibition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Decreased susceptibility to renovascular hypertension in mice lacking the prostaglandin I2 receptor IP

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Cyclooxygenase-2 inhibition decreases renin content and lowers blood pressure in a model of renovascular hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Direct effects of prostaglandin on renal function and renin release in anesthetized dog

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Prostaglandin E2 EP2 and EP4 receptor activation mediates cAMP-dependent hyperpolarization and exocytosis of renin in juxtaglomerular cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Stimulation of renin release by prostaglandin E2 is mediated by EP2 and EP4 receptors in mouse kidneys

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Low plasma renin and reduced renin secretory responses to acute stimuli in conscious COX-2-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Diabetic nephropathy: of mice and men.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Sequential alterations in glomerular prostaglandin and thromboxane synthesis in diabetic rats: relationship to the hyperfiltration of early diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Immunohistochemical and functional correlations of renal cyclooxygenase-2 in experimental diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Cyclooxygenase-2 inhibitor blocks expression of mediators of renal injury in a model of diabetes and hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Altered kidney CYP2C and cyclooxygenase-2 levels are associated with obesity-related albuminuria.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Renal cyclooxygenase-2 in obese Zucker (fatty) rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Expression of cyclooxygenase-2 in the macula densa of human kidney in hypertension, congestive heart failure, and diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Renal prostaglandin E2 receptor (EP) expression profile is altered in streptozotocin and B6-Ins2Akita type I diabetic mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Prevention of diabetic nephropathy in rats by prostaglandin E receptor EP1-selective antagonist

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Lipoxygenases: occurrence, functions, catalysis, and acquisition of substrate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Lipoxygenase genes and their targeted disruption

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Molecular determinants for functional responses to the sulfidopeptide leukotrienes: Metabolism and receptor subclasses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Leukotrienes and lipoxins: structures, biosynthesis, and biological effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

5-Lipoxygenase and leukotrienes. Transgenic mouse and nuclear targeting studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

5-Lipoxygenase and atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

5-Lipoxygenase: Cellular Biology and Molecular Pharmacology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Lipid inflammatory mediators in diabetic vascular disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Lipoxygenase metabolites and cancer metastasis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Lipoxygenase pathways in atherogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Absence of 12/15-lipoxygenase expression decreases lipid peroxidation and atherogenesis in apolipoprotein e-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Reduced Growth Factor Responses in Vascular Smooth Muscle Cells Derived from 12/15-Lipoxygenase–Deficient Mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Selective interleukin-12 synthesis defect in 12/15-lipoxygenase-deficient macrophages associated with reduced atherosclerosis in a mouse model of familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Lipoxygenases as therapeutic targets in the acute and subacute phases of glomerular immune injury.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Gene expression of 5-, 12-, and 15-lipoxygenases and leukotriene receptors along the rat nephron

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Leukotriene D4 is a mediator of proteinuria and glomerular hemodynamic abnormalities in passive Heymann nephritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

12-Hydroxyeicosatetraenoic acid participates in angiotensin II afferent arteriolar vasoconstriction by activating L-type calcium channels

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

12-Lipoxygenase metabolism in mouse distal convoluted tubule cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Relationship between 12/15-lipoxygenase and COX-2 in mesangial cells: potential role in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

12-lipoxygenase is increased in glucose-stimulated mesangial cells and in experimental diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Novel interactions between TGF-{beta}1 actions and the 12/15-lipoxygenase pathway in mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Elevated endothelial nitric oxide bioactivity and resistance to angiotensin-dependent hypertension in 12/15-lipoxygenase knockout mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Differential behavior of mesangial cells derived from 12/15-lipoxygenase knockout mice relative to control mice11See Editorial by Kasinath, p. 1918

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Increased levels of 12(S)-HETE in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

A coding polymorphism in the 12-lipoxygenase gene is associated to essential hypertension and urinary 12(S)-HETE.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Increase in 12-lipoxygenase activity in platelets of spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Platelet lipoxygenase in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

The lipoxygenase inhibitor phenidone protects against proteinuria and stroke in stroke-prone spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Regulation of 12-lipoxygenase by cytokines in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

The effects of leukocyte-type 12/15-lipoxygenase on Id3-mediated vascular smooth muscle cell growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids and blood pressure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

P-450 metabolites of arachidonic acid in the control of cardiovascular function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Biochemical and molecular properties of the cytochrome P450 arachidonic acid monooxygenases.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Kidney CYP450 enzymes: biological actions beyond drug metabolism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Renal and cardiovascular actions of 20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Renal cytochrome P450 omega-hydroxylase and epoxygenase activity are differentially modified by nitric oxide and sodium chloride

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Inhibitors of cytochrome P-450 attenuate the myogenic response of dog renal arcuate arteries

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Arachidonic acid inhibits epithelial Na channel via cytochrome P450 (CYP) epoxygenase-dependent metabolic pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Salt-sensitive hypertension is associated with dysfunctional Cyp4a10 gene and kidney epithelial sodium channel

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

The CYP P450 arachidonic acid monooxygenases: from cell signaling to blood pressure regulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Chronic treatment with tin normalizes blood pressure in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Functional variant of CYP4A11 20-hydroxyeicosatetraenoic acid synthase is associated with essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Association of the T8590C polymorphism of CYP4A11 with hypertension in the MONICA Augsburg echocardiographic substudy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Experimental and/or genetically controlled alterations of the renal microsomal cytochrome P450 epoxygenase induce hypertension in rats fed a high salt diet

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Functions of ceramide in coordinating cellular responses to stress

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Signaling through the sphingomyelin pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Stress-induced apoptosis and the sphingomyelin pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Role of enhanced ceramide generation in DNA damage and cell death in chemical hypoxic injury to LLC-PK1 cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Altered sphingomyelinase and ceramide expression in the setting of ischemic and nephrotoxic acute renal failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Altered ceramide and sphingosine expression during the induction phase of ischemic acute renal failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Involvement of de novo ceramide synthesis in radiocontrast-induced renal tubular cell injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Ceramide synthase is essential for endonuclease-mediated death of renal tubular epithelial cells induced by hypoxia-reoxygenation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Homocysteine activates NADH/NADPH oxidase through ceramide-stimulated Rac GTPase activity in rat mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002192

7 January 2021

Identifiers

DOI

10.1038/SJ.KI.5002192

1 reference

16 August 2017

1 reference